173 related articles for article (PubMed ID: 26489119)
1. [Clinical and immunological comparisons of therapeutic regimens for corneal infiltrates secondary to adenoviral keratoconjunctivitis].
Maychuk DY; Vasil'eva OA; Russu LI; Mezentseva MV
Vestn Oftalmol; 2015; 131(4):49-55. PubMed ID: 26489119
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporine A 1% eye drops for the treatment of subepithelial infiltrates after adenoviral keratoconjunctivitis.
Jeng BH; Holsclaw DS
Cornea; 2011 Sep; 30(9):958-61. PubMed ID: 21673568
[TBL] [Abstract][Full Text] [Related]
3. Topical treatment with 1% cyclosporine for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis.
Levinger E; Slomovic A; Sansanayudh W; Bahar I; Slomovic AR
Cornea; 2010 Jun; 29(6):638-40. PubMed ID: 20458220
[TBL] [Abstract][Full Text] [Related]
4. Comparison of clinical outcome with different treatment regimens in acute adenoviral keratoconjunctivitis.
Asena L; Şıngar Özdemir E; Burcu A; Ercan E; Çolak M; Altınörs DD
Eye (Lond); 2017 May; 31(5):781-787. PubMed ID: 28157224
[TBL] [Abstract][Full Text] [Related]
5. Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study.
Hillenkamp J; Reinhard T; Ross RS; Böhringer D; Cartsburg O; Roggendorf M; De Clercq E; Godehardt E; Sundmacher R
Arch Ophthalmol; 2001 Oct; 119(10):1487-91. PubMed ID: 11594949
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporin A eye drop and subepithelial adenoviral keratoconjunctivitis infiltrates.
Zghal I; Fekih O; Zgolli HM; Chargui S; Malek I; Nacef L
Tunis Med; 2019 May; 97(5):639-643. PubMed ID: 31729734
[TBL] [Abstract][Full Text] [Related]
7. Transepithelial Surface Ablation With Mitomycin C for the Treatment of Chronic Central Corneal Scars Following Adenoviral Keratoconjunctivitis.
Oliveira RF; Ferreira GA; Ghanem VC; Corrêa-Dantas PE; Ghanem RC
J Refract Surg; 2020 Jan; 36(1):55-61. PubMed ID: 31917852
[TBL] [Abstract][Full Text] [Related]
8. Corneal subepithelial infiltrate recurrence sine adenovirus.
Hodge W; Wohl T; Whitcher JP; Margolis TP
Cornea; 1995 May; 14(3):324-5. PubMed ID: 7600819
[TBL] [Abstract][Full Text] [Related]
9. Late-term topical tacrolimus for subepithelial infiltrates resistant to topical steroids and ciclosporin secondary to adenoviral keratoconjunctivitis.
Arici C; Mergen B
Br J Ophthalmol; 2021 May; 105(5):614-618. PubMed ID: 32563992
[TBL] [Abstract][Full Text] [Related]
10. Topical cyclosporine A in severe steroid-dependent childhood phlyctenular keratoconjunctivitis.
Doan S; Gabison E; Gatinel D; Duong MH; Abitbol O; Hoang-Xuan T
Am J Ophthalmol; 2006 Jan; 141(1):62-66. PubMed ID: 16386977
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine a 0.05% eye drops for the treatment of subepithelial infiltrates after epidemic keratoconjunctivitis.
Okumus S; Coskun E; Tatar MG; Kaydu E; Yayuspayi R; Comez A; Erbagci I; Gurler B
BMC Ophthalmol; 2012 Aug; 12():42. PubMed ID: 22900547
[TBL] [Abstract][Full Text] [Related]
12. Tacrolimus for the treatment of subepithelial infiltrates resistant to topical steroids after adenoviral keratoconjunctivitis.
Ghanem RC; Vargas JF; Ghanem VC
Cornea; 2014 Nov; 33(11):1210-3. PubMed ID: 25188789
[TBL] [Abstract][Full Text] [Related]
13. Corticosteroids Versus Cyclosporine for Subepithelial Infiltrates Secondary to Epidemic Keratoconjunctivitis: A Prospective Randomized Double-Blind Study.
Gouider D; Khallouli A; Maalej A; Yousfi MA; Ksiaa I; Bouguerra C; Ajili F; Khairallah M
Cornea; 2021 Jun; 40(6):726-732. PubMed ID: 33201059
[TBL] [Abstract][Full Text] [Related]
14. [Cyclosporine eye drops: A 4-year retrospective study (2009-2013)].
Kauss Hornecker M; Charles Weber S; Brandely Piat ML; Darrodes M; Jomaa K; Chast F
J Fr Ophtalmol; 2015 Oct; 38(8):700-8. PubMed ID: 26371985
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the safety and efficacy of topical Tacrolimus (0.03%) versus dexamethasone (0.05%) for subepithelial infiltrates after adenoviral conjunctivitis.
Bhargava R; Kumar P
Indian J Ophthalmol; 2019 May; 67(5):594-598. PubMed ID: 31007215
[TBL] [Abstract][Full Text] [Related]
16. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
Toker E; Asfuroğlu E
Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564
[TBL] [Abstract][Full Text] [Related]
17. Topical Tacrolimus for Corneal Subepithelial Infiltrates Secondary to Adenoviral Keratoconjunctivitis.
Berisa Prado S; Riestra Ayora AC; Lisa Fernández C; Chacón Rodríguez M; Merayo-Lloves J; Alfonso Sánchez JF
Cornea; 2017 Sep; 36(9):1102-1105. PubMed ID: 28704319
[TBL] [Abstract][Full Text] [Related]
18. Correlation between corneal involvement and anterior chamber flare in epidemic keratoconjunctivitis.
Kiyat P; Palamar M; Yilmaz SG; Emre S
Eur J Ophthalmol; 2020 Sep; 30(5):897-900. PubMed ID: 31111724
[TBL] [Abstract][Full Text] [Related]
19. Human adenoviral type 54 keratoconjunctivitis accompanied by stellate keratitis and keratic precipitates: two cases.
Matsuura K; Terasaka Y; Uchio E; Saeki Y; Fujimoto T; Hanaoka N; Miyazaki D; Inoue Y
BMC Ophthalmol; 2019 Jan; 19(1):7. PubMed ID: 30616635
[TBL] [Abstract][Full Text] [Related]
20. [Local cyclosporin A therapy of nummuli after epidemic keratoconjunctivitis--case report].
Reinhard T; Sundmacher R
Klin Monbl Augenheilkd; 1997 Mar; 210(3):165-8. PubMed ID: 9206749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
